東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Pharmacology- Statistical methods." ]

切換: 標籤 | MARC模式 | ISBD

Nonclinical statistics for pharmaceu...

Zhang, Lanju.

FindBook

Google Book

Amazon

博客來

Nonclinical statistics for pharmaceutical and biotechnology industries

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Nonclinical statistics for pharmaceutical and biotechnology industries/ edited by Lanju Zhang.
其他作者:	Zhang, Lanju.
出版者:	Cham :Springer International Publishing : : 2016.,
面頁冊數:	xxii, 698 p. :ill. (some col.), digital ;24 cm.
內容註:	Introduction to Nonclinical Statistics for Pharmaceutical and Biotechnology Industries -- Regulatory Nonclinical Statistics -- How to be a good nonclinical statistician -- Statistical Methods for Drug Discovery -- High-throughput Screening Data Analysis -- Quantitative-Structure Activity Relationship Modeling and Cheminformatics -- GWAS for Drug Discovery -- Statistical applications in Design and Analysis of In-Vitro Safety Screening Assays -- Nonclinical safety assessment: an introduction for statisticians -- General Toxicology, Safety Pharmacology, Reproductive Toxicology and Juvenile Toxicology Studies -- Clinical Assays for Biological Macromolecules -- Recent Research Projects by FDA's Pharmacology and Toxicology Statistics Team -- Design and evaluation of drug combination studies -- Biomarkers -- Overview of Drug Development and Statistical Tools for Manufacturing and Testing -- Assay Validation -- Lifecycle Approach to Bioassay -- Quality by Design: Building Quality into Products and Processes -- Process Validation -- Acceptance Sampling -- Process Capability and Statistical Process Control -- Statistical Considerations for Stability and the Estimation of Shelf Life -- In Vitro Dissolution Testing: Statistical Approaches and Issues -- Assessing Content Uniformity -- Chemometrics and Predictive Modelling -- Statistical Methods for Comparability Studies.
Contained By:	Springer eBooks
標題:	Pharmacology - Statistical methods. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-23558-5
ISBN:	9783319235585$q(electronic bk.)

Nonclinical statistics for pharmaceutical and biotechnology industries
Nonclinical statistics for pharmaceutical and biotechnology industries[electronic resource] /edited by Lanju Zhang. - Cham :Springer International Publishing :2016. - xxii, 698 p. :ill. (some col.), digital ;24 cm. - Statistics for biology and health,1431-8776. - Statistics for biology and health..

Introduction to Nonclinical Statistics for Pharmaceutical and Biotechnology Industries -- Regulatory Nonclinical Statistics -- How to be a good nonclinical statistician -- Statistical Methods for Drug Discovery -- High-throughput Screening Data Analysis -- Quantitative-Structure Activity Relationship Modeling and Cheminformatics -- GWAS for Drug Discovery -- Statistical applications in Design and Analysis of In-Vitro Safety Screening Assays -- Nonclinical safety assessment: an introduction for statisticians -- General Toxicology, Safety Pharmacology, Reproductive Toxicology and Juvenile Toxicology Studies -- Clinical Assays for Biological Macromolecules -- Recent Research Projects by FDA's Pharmacology and Toxicology Statistics Team -- Design and evaluation of drug combination studies -- Biomarkers -- Overview of Drug Development and Statistical Tools for Manufacturing and Testing -- Assay Validation -- Lifecycle Approach to Bioassay -- Quality by Design: Building Quality into Products and Processes -- Process Validation -- Acceptance Sampling -- Process Capability and Statistical Process Control -- Statistical Considerations for Stability and the Estimation of Shelf Life -- In Vitro Dissolution Testing: Statistical Approaches and Issues -- Assessing Content Uniformity -- Chemometrics and Predictive Modelling -- Statistical Methods for Comparability Studies.

This book serves as a reference text for regulatory, industry and academic statisticians and also a handy manual for entry level Statisticians. Additionally it aims to stimulate academic interest in the field of Nonclinical Statistics and promote this as an important discipline in its own right. This text brings together for the first time in a single volume a comprehensive survey of methods important to the nonclinical science areas within the pharmaceutical and biotechnology industries. Specifically the Discovery and Translational sciences, the Safety/Toxiology sciences, and the Chemistry, Manufacturing and Controls sciences. Drug discovery and development is a long and costly process. Most decisions in the drug development process are made with incomplete information. The data is rife with uncertainties and hence risky by nature. This is therefore the purview of Statistics. As such, this book aims to introduce readers to important statistical thinking and its application in these nonclinical areas. The chapters provide as appropriate, a scientific background to the topic, relevant regulatory guidance, current statistical practice, and further research directions.

ISBN: 9783319235585$q(electronic bk.)

Standard No.: 10.1007/978-3-319-23558-5doiSubjects--Topical Terms:

2182481
Pharmacology
--Statistical methods.

LC Class. No.: RS57

Dewey Class. No.: 615.1072

Nonclinical statistics for pharmaceutical and biotechnology industries
LDR:03620nmm a2200337 a 4500 001 2030570
003 DE-He213
005 20160818133345.0
006 m d
007 cr nn 008maaau
008 160908s2016 gw s 0 eng d
020 $a 9783319235585$q(electronic bk.)
020 $a 9783319235578$q(paper)
024 7 $a 10.1007/978-3-319-23558-5 $2 doi
035 $a 978-3-319-23558-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RS57
072 7 $a PBT $2 bicssc
072 7 $a MBNS $2 bicssc
072 7 $a MED090000 $2 bisacsh
082 0 4 $a 615.1072 $2 23
090 $a RS57 $b .N812 2016
245 0 0 $a Nonclinical statistics for pharmaceutical and biotechnology industries $h [electronic resource] / $c edited by Lanju Zhang.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xxii, 698 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Statistics for biology and health, $x 1431-8776
505 0 $a Introduction to Nonclinical Statistics for Pharmaceutical and Biotechnology Industries -- Regulatory Nonclinical Statistics -- How to be a good nonclinical statistician -- Statistical Methods for Drug Discovery -- High-throughput Screening Data Analysis -- Quantitative-Structure Activity Relationship Modeling and Cheminformatics -- GWAS for Drug Discovery -- Statistical applications in Design and Analysis of In-Vitro Safety Screening Assays -- Nonclinical safety assessment: an introduction for statisticians -- General Toxicology, Safety Pharmacology, Reproductive Toxicology and Juvenile Toxicology Studies -- Clinical Assays for Biological Macromolecules -- Recent Research Projects by FDA's Pharmacology and Toxicology Statistics Team -- Design and evaluation of drug combination studies -- Biomarkers -- Overview of Drug Development and Statistical Tools for Manufacturing and Testing -- Assay Validation -- Lifecycle Approach to Bioassay -- Quality by Design: Building Quality into Products and Processes -- Process Validation -- Acceptance Sampling -- Process Capability and Statistical Process Control -- Statistical Considerations for Stability and the Estimation of Shelf Life -- In Vitro Dissolution Testing: Statistical Approaches and Issues -- Assessing Content Uniformity -- Chemometrics and Predictive Modelling -- Statistical Methods for Comparability Studies.
520 $a This book serves as a reference text for regulatory, industry and academic statisticians and also a handy manual for entry level Statisticians. Additionally it aims to stimulate academic interest in the field of Nonclinical Statistics and promote this as an important discipline in its own right. This text brings together for the first time in a single volume a comprehensive survey of methods important to the nonclinical science areas within the pharmaceutical and biotechnology industries. Specifically the Discovery and Translational sciences, the Safety/Toxiology sciences, and the Chemistry, Manufacturing and Controls sciences. Drug discovery and development is a long and costly process. Most decisions in the drug development process are made with incomplete information. The data is rife with uncertainties and hence risky by nature. This is therefore the purview of Statistics. As such, this book aims to introduce readers to important statistical thinking and its application in these nonclinical areas. The chapters provide as appropriate, a scientific background to the topic, relevant regulatory guidance, current statistical practice, and further research directions.
650 0 $a Pharmacology $x Statistical methods. $3 2182481
650 0 $a Biotechnology $x Statistical methods. $3 2182482
650 1 4 $a Statistics. $3 517247
650 2 4 $a Statistics for Life Sciences, Medicine, Health Sciences. $3 891086
650 2 4 $a Medicine/Public Health, general. $3 891342
650 2 4 $a Pharmacology/Toxicology. $3 890953
700 1 $a Zhang, Lanju. $3 2182480
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Statistics for biology and health. $3 923270
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-23558-5
950 $a Mathematics and Statistics (Springer-11649)